share_log

BRIEF-Appili Therapeutics Announces Change To Board Of Directors

reuters ·  Nov 19, 2021 20:48

Nov 19 (Reuters) - Appili Therapeutics Inc APLI.TO :

* APPILI THERAPEUTICS ANNOUNCES POSITIVE ONE YEAR CHALLENGE RESULTS FROM PRECLINICAL STUDY EVALUATING BIODEFENSE VACCINE CANDIDATE ATI-1701 AND CHANGE TO BOARD OF DIRECTORS

* APPILI THERAPEUTICS INC - JOSEF VEJVODA HAS RESIGNED FROM COMPANY'S BOARD OF DIRECTORS

* APPILI THERAPEUTICS - MAKING CONTINUED PROGRESS ON MANUFACTURING AND IND-ENABLING ACTIVITIES TO ADVANCE ATI-1701 INTO CLINIC

Source text for Eikon: ID:nBwbPQ2TRa Further company coverage: APLI.TO

((Reuters.Briefs@thomsonreuters.com;))

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment